R. Pasvolsky Et Al. , "A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.," The Journal of experimental medicine , vol.204, no.7, pp.1571-82, 2007
Pasvolsky, R. Et Al. 2007. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.. The Journal of experimental medicine , vol.204, no.7 , 1571-82.
Pasvolsky, R., Feigelson, S. W., Kilic, S. Ş., Simon, A. J., Tal-Lapidot, G., Grabovsky, V., ... Crittenden, J. R.(2007). A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.. The Journal of experimental medicine , vol.204, no.7, 1571-82.
Pasvolsky, Ronit Et Al. "A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.," The Journal of experimental medicine , vol.204, no.7, 1571-82, 2007
Pasvolsky, Ronit Et Al. "A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.." The Journal of experimental medicine , vol.204, no.7, pp.1571-82, 2007
Pasvolsky, R. Et Al. (2007) . "A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.." The Journal of experimental medicine , vol.204, no.7, pp.1571-82.
@article{article, author={Ronit Pasvolsky Et Al. }, title={A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.}, journal={The Journal of experimental medicine}, year=2007, pages={1571-82} }